Iron chelation therapy aims to deprive cancer cells of the iron necessary for their growth. Chelating agents bind free iron, thereby reducing its availability and limiting the oxidative stress that contributes to cancer progression. This can lead to cell cycle arrest, apoptosis, and reduced tumor growth.
